Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2179 (LINC02179)

Target
LINC02179
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Other (non-protein coding RNA)
01

Overview

LINC02179, also known as Long intergenic non-protein coding RNA 2179 and by aliases such as RP11-189E14.4, is a long non-coding RNA transcript gene located in the human genome. LincRNAs like LINC02179 are defined by their absence of protein-coding potential and their positioning in intergenic regions—distinct from other long non-coding RNAs that may overlap coding loci. Generally, lincRNAs participate in fine-tuning gene expression, chromatin architecture, transcriptional regulation, and RNA stabilization, and may show tissue specificity in their activities[3]. While thousands of lincRNAs have been discovered, only a minority have been directly linked to defined molecular or disease roles, and for LINC02179 specifically, there is no detailed functional, disease, or pharmacological annotation[1][3]. As such, LINC02179 should be considered a non-protein coding RNA lacking current evidence as a drug target or clinical biomarker.

Other names
RP11-189E14.4RP11-189E14.4 (duplicate, sometimes appears in databases)LINC02179
02

Mechanism of action

None known; no drugs reported or predicted to act directly on LINC02179[1].

03

Biological functions

Chromatin remodeling (general function associated with lincRNAs[3])Transcriptional regulation (common to lincRNAs[3])RNA stabilization (typical of the broader lincRNA family[3])Other (fine-tune gene expression with tissue specificity[3])
04

Disease associations

Other (general mention: certain lincRNAs are involved in cancer, immune modulation, and development[3]; however, LINC02179 itself has no specific disease association documented as of this search[1])

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2179 (LINC02179).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2179 (LINC02179).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call